Pharmaceutical brand substitution in Australia - Are there multiple switches per prescription?

Australian and New Zealand Journal of Public Health

Volumn 31, Issue 4, 2007, Pages 348-352

  Kalisch, Lisa M ^a   Roughead, Elizabeth E ^a   Gilbert, Andrew L ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Generic drugs; Generic substitution; Pharmaceutical policy; Pharmaco epidemiology

Indexed keywords

ATENOLOL; CITALOPRAM; ENALAPRIL; GENERIC DRUG; METFORMIN; OMEPRAZOLE; RAMIPRIL; SIMVASTATIN;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG CHOICE; DRUG UTILIZATION; PHARMACEUTICAL CARE; PHARMACY; PRESCRIPTION;

DRUGS, GENERIC; HUMANS; INSURANCE CLAIM REVIEW; SOUTH AUSTRALIA; THERAPEUTIC EQUIVALENCY;

EID: 34548072223     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2007.00085.x     Document Type: Article

References (12)

1. Australian General Practice Network [home page on the Internet]. Canberra (AUST): Australian Divisions of General Practice Ltd; 2003 [cited 2004 Oct 25]. GPs Call for "One Switch per Script". Available from: http://www.adgp.com.au/client_images/ 5024.pdf
2. Pharmaceutical Health and Rational Use of Medicines. Consumer Perspectives on Managing Multiple Medicines. Canberra (AUST): Consumer Sub-Committee, PHARM; 2001.
3. Hassali M, Kong D, Stewart K. Generic medicines: Perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicines. 2006;3(3):214-25.
4. Sweet G, Wilson S. The 3D Labels Project. Melbourne (AUST): Dandenong District Divisions of General Practice, Pharmacy Guild of Australia; 2004.
5. Pharmaceutical Society of Australia. Guidelines for Pharmacists on PBS Brand Substitution. Australian Pharmacist. 2004;23(9):668.
6. AMA wrong on brand substitution. Australian Pharmacist. 2006;25(7):506.
7. Department ofHealth and Ageing [publications page on the Internet]. Canberra (AUST): Commonwealth of Australia; 2005 [cited 2006 Apr 3]. Pharmaceutical Benefits Pricing Authority Annual Report for the Year Ended 30 June 2005. Available from: http://www.health.gov.au/ internet/wcms/publishing.nsf/Content/350C5B2F2D00D2C2CA2570D7001CD22A/ $File/04-05%20PBPA%20Annual%20Report.pdf
8. Department of Health and Ageing. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Effective from 1 April 2006. Canberra (AUST): Commonwealth of Australia; 2006.
9. Hall A. Proposed generic restriction not practical. Australian Pharmacist. 2003;22(2):110.
10. Drug switch confusion debated. Australian Journal of Pharmacy. 2003;84:76.
11. Australian Medical Association [publication page on the Internet]. Canberrra (AUST): Federal Secretariat, AMA; 2006 [cited 2006 May 23]. AMA Brand Substitution Survey. Available from: http://www.ama.com.au/web.nsf/doc/WEEN-6PX29R/$file/ Brand_substitution_survey_results_May_2006.pdf
12. Hall A. The Facts on Brand Substitution. AMA Wrong on Brand Substitution [media release page on the Internet]. Canberra (AUST): Pharmaceutical Society of Australia; 2006 June 1 [cited 2007 July 13]. Available from: http://www.psa.org.au/site.php?id=1054.